GO:0032980 keratinocyte activation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032980 (keratinocyte activation) describes the morphological and behavioral switch of keratinocytes into a migratory, hyperproliferative state that produces growth factors and cytokines.
• The keratinocyte activation cycle is driven by injury, inflammation, and soluble ligands, and is central to wound healing and inflammatory skin disease.
• Autophagy in keratinocytes is required for their activation and for subsequent fibroblast activation during wound healing.
• IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis.
• S1PR3 sustains a positive feedback loop that maintains STAT3 activation and keratinocyte hyperproliferation in psoriasis.
• Keratinocyte activation is experimentally tractable using CRISPR knockout, point-mutation, knock-in, and overexpression models combined with transcriptomics and imaging.
Description
Keratinocyte activation (GO:0032980) is the biological process by which keratinocytes change their morphology or behavior in response to an activating factor such as a cellular or soluble ligand. Upon activation, keratinocytes become migratory and hyperproliferative and produce growth factors and cytokines, a phenotypic switch that is fundamental to epidermal repair and to inflammatory skin pathology. The concept of a keratinocyte activation cycle was formalized to explain how these cells reversibly alter their differentiation program during wound healing and in diseases such as psoriasis. Because activated keratinocytes both respond to and secrete inflammatory mediators, they act as signaling hubs that coordinate epidermal and dermal responses. Research on this process has revealed that autophagy is required for keratinocyte activation and for the subsequent activation of fibroblasts during wound healing. In parallel, cytokine-driven pathways such as IL-17A/ACT1/YAP-AREG and S1PR3/STAT3 have been shown to sustain keratinocyte hyperproliferation in psoriasis. Understanding GO:0032980 therefore requires integrating cell-biological, immunological, and genetic approaches, and it has direct relevance to wound repair, inflammatory skin disease, and epidermal tumor biology.
keratinocyte activation At A Glance
| GO ID | GO:0032980 |
|---|---|
| GO term | keratinocyte activation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Morphological and behavioral switch of keratinocytes to a migratory, hyperproliferative, cytokine- and growth-factor-producing state |
| Trigger | Exposure to activating factors such as cellular or soluble ligands |
| Key cellular outcomes | Increased migration, hyperproliferation, and secretion of growth factors and cytokines |
| Representative pathways | Autophagy-dependent activation, IL-17A/ACT1/YAP-AREG signaling, S1PR3/STAT3 feedback |
| Disease relevance | Wound healing, psoriasis, and other inflammatory skin conditions |
What Is GO:0032980?
GO:0032980 (keratinocyte activation) is defined as a change in the morphology or behavior of a keratinocyte resulting from exposure to an activating factor such as a cellular or soluble ligand. Upon activation, keratinocytes become migratory and hyperproliferative, and produce growth factors and cytokines. In practical terms, this GO term captures the transition from a quiescent, differentiating keratinocyte to an activated, repair-associated or inflammation-associated phenotype.
Why Is keratinocyte activation Important in Cell Biology?
Keratinocyte activation is important because it is the pivotal epidermal response that converts a barrier cell into a motile, proliferative, and immunomodulatory cell, thereby driving wound re-epithelialization and contributing to inflammatory skin disease. The activation cycle concept explains how keratinocytes reversibly exit and re-enter differentiation states, which is essential for understanding epidermal homeostasis and repair. Mechanistic studies have shown that autophagy is required for keratinocyte activation and for the subsequent activation of fibroblasts during wound healing, linking epidermal stress responses to dermal remodeling. In psoriasis, IL-17A promotes keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis, and S1PR3 sustains a positive feedback loop that maintains STAT3 activation and hyperproliferation. These findings make GO:0032980 a high-value target for research into wound repair, inflammatory dermatoses, and epidermal growth control.
• Defines the transition of keratinocytes to a migratory and hyperproliferative state during wound healing.
• Explains how keratinocytes produce growth factors and cytokines that coordinate dermal repair.
• Provides a mechanistic framework for psoriasis-associated keratinocyte hyperproliferation.
• Links autophagy in keratinocytes to activation of fibroblasts and efficient wound healing.
• Connects cytokine signaling (IL-17A, S1PR3) to transcriptional and proliferative programs in keratinocytes.
• Supports research on epidermal growth control and inflammatory skin disease models.
• Offers a conceptual basis for the keratinocyte activation cycle in differentiation and re-epithelialization.
• Enables experimental dissection using CRISPR-based knockout, knock-in, and overexpression models.
• Relevant to drug discovery for inflammatory skin conditions and wound care.
• Provides a bridge between epidermal cell biology and immunology in skin.
What Happens During keratinocyte activation?
Triggering by activating factors
In simple terms: Keratinocytes switch on when they sense injury or inflammatory signals.
Keratinocyte activation is initiated when keratinocytes are exposed to activating factors such as cellular or soluble ligands, which change their morphology or behavior. This triggering step is the defining event of GO:0032980 and sets in motion the migratory and hyperproliferative program. In wound healing, this activation is coupled to autophagic processes that are required for keratinocytes to become activated.
Acquisition of a migratory and hyperproliferative phenotype
In simple terms: Activated keratinocytes start moving and dividing more than usual.
Upon activation, keratinocytes become migratory and hyperproliferative, which allows them to cover wounds and expand the epidermis. This phenotypic switch is a hallmark of the keratinocyte activation cycle and distinguishes activated keratinocytes from quiescent, differentiating cells. The hyperproliferative component is particularly evident in psoriasis, where cytokine-driven signaling sustains keratinocyte proliferation.
Secretion of growth factors and cytokines
In simple terms: Activated keratinocytes release signals that recruit and stimulate other cells.
Activated keratinocytes produce growth factors and cytokines, making them active participants in the inflammatory and repair microenvironment. This secretory output is part of the definition of GO:0032980 and explains how keratinocytes communicate with fibroblasts and immune cells. Autophagy in keratinocytes enables the activation of keratinocytes and fibroblasts and facilitates wound healing, highlighting the functional importance of this secretory program.
Cytokine-driven amplification loops
In simple terms: Inflammatory signals can lock keratinocytes into an activated state.
IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis, illustrating how a soluble ligand can drive the activated phenotype. S1PR3-driven positive feedback sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis, providing a mechanism for persistent activation. These amplification loops are central to the pathological consequences of keratinocyte activation in inflammatory skin disease.
Resolution and reversibility
In simple terms: Activation is normally reversible once the trigger is removed.
The keratinocyte activation cycle is conceived as a reversible process in which activated keratinocytes can return to a differentiated state after the activating stimulus subsides. This reversibility is essential for restoring epidermal homeostasis after wound healing. Failure to resolve activation contributes to chronic inflammatory states such as psoriasis.
Key Genes Involved in GO:0032980 keratinocyte activation
The following genes and proteins have been experimentally implicated in keratinocyte activation or in the signaling pathways that sustain it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KRT6A | Keratin marker associated with the activated keratinocyte phenotype | Readout of keratinocyte activation cycle |
| KRT16 | Keratin marker associated with the activated keratinocyte phenotype | Readout of keratinocyte activation cycle |
| KRT17 | Keratin marker associated with the activated keratinocyte phenotype | Readout of keratinocyte activation cycle |
| IL17A | Cytokine that promotes keratinocyte proliferation | Drives psoriasis-associated activation via ACT1/YAP-AREG |
| ACT1 | Adaptor in IL-17A signaling | Required for IL-17A-induced keratinocyte proliferation |
| YAP | Transcriptional co-activator downstream of IL-17A | Mediates YAP-AREG axis in keratinocytes |
| AREG | Growth factor induced by YAP | Effector of IL-17A-driven keratinocyte proliferation |
| S1PR3 | Sphingosine-1-phosphate receptor | Sustains STAT3 activation and hyperproliferation |
| STAT3 | Transcription factor downstream of S1PR3 | Maintains keratinocyte hyperproliferation in psoriasis |
| ATG5 | Autophagy-related protein | Autophagy enables keratinocyte and fibroblast activation |
| ATG7 | Autophagy-related protein | Autophagy enables keratinocyte and fibroblast activation |
| BECN1 | Autophagy-related protein | Autophagy enables keratinocyte and fibroblast activation |
| MAP1LC3B | Autophagosome marker | Autophagy enables keratinocyte and fibroblast activation |
| EGFR | Receptor tyrosine kinase | Supports keratinocyte growth and survival |
| CISD2 | Longevity-associated protein | Attenuates senescence in human keratinocytes |
| JAK | Janus kinase family | JAK inhibition ameliorates EGFR inhibitor-induced rash |
| MITF | Melanocyte transcription factor | Keratinocyte-melanocyte interactions during melanosome transfer |
How Is keratinocyte activation Regulated?
Keratinocyte activation is regulated by a combination of autophagic, cytokine, and transcriptional inputs. Autophagy in keratinocytes is required for their activation and for the subsequent activation of fibroblasts, indicating that autophagic machinery regulates the onset of the activated state. IL-17A promotes keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis, providing a ligand-driven regulatory pathway. S1PR3-driven positive feedback sustains STAT3 activation and keratinocyte hyperproliferation, showing that receptor-mediated feedback loops can maintain the activated phenotype. The keratinocyte activation cycle framework further implies that activation is reversible and context-dependent, with differentiation state influencing responsiveness.
keratinocyte activation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL17A | Psoriasis-associated keratinocyte proliferation | Keratinocyte overexpression or stimulation model |
| ACT1 | IL-17A signaling in psoriasis | CRISPR knockout in keratinocytes |
| S1PR3 | Psoriasis hyperproliferation | Knockout or overexpression in keratinocyte lines |
| STAT3 | Psoriasis hyperproliferation | Point-mutation or knockout models |
| ATG5 | Wound healing via autophagy | Knockout in keratinocytes |
Psoriasis
Psoriasis is characterized by keratinocyte hyperproliferation and inflammation, and IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis. S1PR3-driven positive feedback sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis, reinforcing the role of sustained activation loops in disease. These findings directly link GO:0032980 to psoriasis pathogenesis.
Wound healing
Keratinocyte activation is essential for re-epithelialization, and autophagy in keratinocytes enables the activation of keratinocytes and fibroblasts and facilitates wound healing. The migratory and hyperproliferative phenotype defined by GO:0032980 is required for keratinocytes to cover wounds. Defects in activation would therefore be expected to impair wound repair.
EGFR inhibitor-induced rash
Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans, indicating that cytokine signaling pathways intersect with keratinocyte activation in drug-induced skin toxicity. This provides a clinical context in which modulating keratinocyte activation has therapeutic benefit.
Keratinocyte senescence and aging
Hesperetin activates CISD2 to attenuate senescence in human keratinocytes from an older person and rejuvenates naturally aged skin in mice, linking keratinocyte state to aging phenotypes. This suggests that keratinocyte activation and senescence are interrelated processes relevant to skin aging.
From keratinocyte activation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for keratinocyte activation? | CRISPR knockout in primary or immortalized keratinocytes |
| Does a specific point mutation alter activation signaling? | CRISPR point-mutation knock-in |
| Does a disease-associated variant affect activation? | Knock-in of the variant allele |
| Where and when is a protein expressed during activation? | Tagged knock-in for imaging |
| Does increased gene dosage drive hyperproliferation? | Overexpression in keratinocytes |
| Which pathways are downstream of an activation trigger? | CRISPR library screening with transcriptomic readout |
How to Study the keratinocyte activation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes | Define activation signature |
| Autophagy markers | Autophagic flux | Test requirement for activation |
| STAT3 activity assays | STAT3 activation status | Assess S1PR3 feedback |
| YAP-AREG readouts | YAP target expression | Assess IL-17A signaling |
| Live-cell imaging | Migration | Measure activated phenotype |
| Proliferation assays | Cell division | Measure hyperproliferation |
| CRISPR screening | Gene requirement | Identify regulators of activation |
Transcriptomic profiling
RNA-seq of keratinocytes before and after activation can identify genes whose expression changes during the transition to a migratory and hyperproliferative state. Such profiling is useful for defining the molecular signature of GO:0032980 and for comparing normal activation with pathological hyperproliferation.
Autophagy and signaling assays
Autophagy can be monitored using markers such as MAP1LC3B to test whether autophagic machinery is required for keratinocyte activation. Signaling assays for STAT3 and YAP-AREG can measure the activity of pathways that sustain activation.
Imaging of migration and proliferation
Live-cell imaging and proliferation assays allow direct measurement of the migratory and hyperproliferative phenotype that defines activated keratinocytes. These readouts are essential for confirming that a genetic perturbation alters the activation state.
CRISPR-based perturbation
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in keratinocyte activation. Library screening can nominate pathways that regulate the activated phenotype.
How CRISPR Can Be Used to Study GO:0032980 keratinocyte activation
Knockout
CRISPR knockout of candidate genes such as ACT1 or ATG5 can test whether they are required for keratinocyte activation and downstream phenotypes. Knockout models are particularly useful for establishing necessity in the activation pathway.
Point Mutation
Point-mutation knock-in can model specific amino acid changes in signaling proteins such as STAT3 to dissect their role in sustained keratinocyte hyperproliferation. This approach allows precise structure-function analysis within the activation pathway.
Knock-in
Knock-in of tagged alleles or disease-associated variants enables tracking of protein localization and testing of variant effects on keratinocyte activation. Tagged knock-in is especially useful for imaging dynamic activation processes.
Overexpression
Overexpression of genes such as IL17A or S1PR3 can drive keratinocytes into an activated, hyperproliferative state and test sufficiency. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports keratinocyte activation Research
Researchers studying keratinocyte activation-related genes often need to determine whether a candidate gene is causally involved in the migratory, hyperproliferative, and secretory phenotype defined by GO:0032980. Establishing causality requires precise genetic perturbation in relevant keratinocyte models, coupled with functional readouts of activation.
Contact EDITGENE today to design your custom CRISPR model for keratinocyte activation research.
Frequently Asked Questions About keratinocyte activation
What is keratinocyte activation (GO:0032980)?
It is the process by which keratinocytes change their morphology or behavior in response to activating factors, becoming migratory and hyperproliferative and producing growth factors and cytokines.
What genes are involved in keratinocyte activation?
Genes implicated include IL17A, ACT1, YAP, AREG, S1PR3, STAT3, and autophagy-related genes such as ATG5, ATG7, and BECN1.
How is keratinocyte activation related to wound healing?
Autophagy in keratinocytes enables their activation and the activation of fibroblasts, facilitating wound healing.
What role does IL-17A play in keratinocyte activation?
IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of the YAP-AREG axis.
How does S1PR3 contribute to keratinocyte hyperproliferation?
S1PR3-driven positive feedback sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis.
What is the keratinocyte activation cycle?
It is a framework describing how keratinocytes reversibly alter their differentiation program during activation and repair.
Can CRISPR be used to study keratinocyte activation?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test causal roles of genes in activation.
Which diseases involve abnormal keratinocyte activation?
Psoriasis and impaired wound healing are prominent examples, with additional relevance to EGFR inhibitor-induced rash and skin aging.
What methods measure keratinocyte activation?
RNA-seq, autophagy markers, STAT3 and YAP-AREG readouts, live-cell imaging, and proliferation assays are commonly used.
Why is autophagy important for keratinocyte activation?
Autophagy is required for keratinocyte activation and for subsequent fibroblast activation during wound healing.
Conclusion
GO:0032980 (keratinocyte activation) captures a central epidermal response in which keratinocytes become migratory, hyperproliferative, and secretory in response to activating factors. This process is required for wound healing and is pathologically amplified in psoriasis through IL-17A/ACT1/YAP-AREG and S1PR3/STAT3 signaling. Studying keratinocyte activation with CRISPR-based models and functional readouts will continue to clarify how this process can be therapeutically modulated in inflammatory skin disease and repair.
References
- 1. Qiang L et al.. 2021. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.. Autophagy 17(9):2128-2143 PMID: 32866426
- 2. Yu Z et al.. 2022. IL-17A Promotes Psoriasis-Associated Keratinocyte Proliferation through ACT1-Dependent Activation of YAP-AREG Axis.. J Invest Dermatol 142(9):2343-2352 PMID: 35304250
- 3. Freedberg IM et al.. 2001. Keratins and the keratinocyte activation cycle.. J Invest Dermatol 116(5):633-40 PMID: 11348449
- 4. Lian P et al.. 2025. S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis.. Cell Death Dis 16(1):31 PMID: 39833165
- 5. Seiberg M. 2001. Keratinocyte-melanocyte interactions during melanosome transfer.. Pigment Cell Res 14(4):236-42 PMID: 11549105
- 6. Kwon PK et al.. 2021. Isoprocurcumenol Supports Keratinocyte Growth and Survival through Epidermal Growth Factor Receptor Activation.. Int J Mol Sci 22(22) PMID: 34830467
- 7. You Q et al.. 2024. Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans.. Sci Transl Med 16(752):eabq7074 PMID: 38896602
- 8. Shen ZQ et al.. 2024. Hesperetin activates CISD2 to attenuate senescence in human keratinocytes from an older person and rejuvenates naturally aged skin in mice.. J Biomed Sci 31(1):15 PMID: 38263133
